CA2408611A1 - Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages - Google Patents

Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages Download PDF

Info

Publication number
CA2408611A1
CA2408611A1 CA002408611A CA2408611A CA2408611A1 CA 2408611 A1 CA2408611 A1 CA 2408611A1 CA 002408611 A CA002408611 A CA 002408611A CA 2408611 A CA2408611 A CA 2408611A CA 2408611 A1 CA2408611 A1 CA 2408611A1
Authority
CA
Canada
Prior art keywords
composition
beverage
present
compositions
chondroprotective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002408611A
Other languages
English (en)
Inventor
Kris Eugene Spence
Judith Lynn Harris
Robert Joseph Sarama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2408611A1 publication Critical patent/CA2408611A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

La présente invention concerne des nécessaires destinés à promouvoir un ou plusieurs avantages de soins de santé déterminés. En particulier, les nécessaires de l'invention comprennent: a) une composition contenant un ou plusieurs agents de protection des cartilages et au moins de l'eau; et b) des informations telles que: i) des informations sur la posologie; ii) des instructions ou des recommandations relatives à l'ingestion de la composition environ 4 heures après ingestion d'un aliment ou d'une boisson; et iii) ces informations combinées. L'invention concerne aussi des nécessaires qui comprennent a) une composition contenant un ou plusieurs agents de protection des cartilages et au moins 80 % d'eau; et b) un aliment ou une boisson séparé(e). L'invention concerne en outre des méthodes qui améliorent un avantage associé à une composition contenant un ou plusieurs agents de protection des cartilages et de l'eau. La méthode consiste à administrer la composition à un mammifère environ 4 heures après administration d'un aliment ou d'une boisson.
CA002408611A 2000-06-02 2001-06-01 Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages Abandoned CA2408611A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58651400A 2000-06-02 2000-06-02
US09/586,514 2000-06-02
PCT/US2001/017721 WO2001093833A2 (fr) 2000-06-02 2001-06-01 Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages

Publications (1)

Publication Number Publication Date
CA2408611A1 true CA2408611A1 (fr) 2001-12-13

Family

ID=24346049

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002408611A Abandoned CA2408611A1 (fr) 2000-06-02 2001-06-01 Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages

Country Status (8)

Country Link
EP (1) EP1289531A2 (fr)
JP (1) JP2003535121A (fr)
CN (1) CN1431908A (fr)
AU (1) AU2001266648A1 (fr)
BR (1) BR0111378A (fr)
CA (1) CA2408611A1 (fr)
MX (1) MXPA02011940A (fr)
WO (1) WO2001093833A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003339318A (ja) * 2002-05-28 2003-12-02 Sanei Gen Ffi Inc 長期保存に安定な茶類飲料とその製造方法
JP4143387B2 (ja) * 2002-11-21 2008-09-03 株式会社アセロラフーズ 健康食品
AU2003903037A0 (en) 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
RU2368238C2 (ru) * 2004-12-30 2009-09-27 Хилл`С Пет Ньютришн, Инк. Способы улучшения вкуса композиций для потребления животными
US20090220649A1 (en) * 2005-03-14 2009-09-03 Sapporo Holding Limited Nutritionally Balanced Food or Beverage Product
US20080280274A1 (en) * 2005-06-01 2008-11-13 Kim Gene Friesen Methods For Enhancing Palatability of Compositions for Animal Consumption
US8956677B2 (en) 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
CN116196319B (zh) * 2021-11-30 2024-06-04 内蒙古伊利实业集团股份有限公司 低聚糖在保护软骨中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387C3 (de) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
US4766209A (en) * 1986-03-10 1988-08-23 Nestec S. A. Amino sugar carbonating agents and their preparation
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
EP0991413A1 (fr) * 1997-04-10 2000-04-12 Richardson Labs, Inc. Composition renfermant une proteine de collagene hydrolysee et de la glucosamine, pour le traitement des arthroses
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
JP2000166467A (ja) * 1998-12-10 2000-06-20 Nippon Kefia Kk 乳発酵産物及びハーブ類を含有してなる健康食品
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
DE19859771C1 (de) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
JP4173606B2 (ja) * 1999-06-18 2008-10-29 サントリー株式会社 低酸性飲料の製造方法
JP4249853B2 (ja) * 1999-08-09 2009-04-08 焼津水産化学工業株式会社 経口用皮膚潤い改善剤

Also Published As

Publication number Publication date
JP2003535121A (ja) 2003-11-25
AU2001266648A1 (en) 2001-12-17
WO2001093833A2 (fr) 2001-12-13
MXPA02011940A (es) 2003-04-22
BR0111378A (pt) 2003-06-17
EP1289531A2 (fr) 2003-03-12
CN1431908A (zh) 2003-07-23
WO2001093833A3 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
US20020132780A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
US20030069202A1 (en) Compositions, kits, and methods for promoting defined health benefits
US6413558B1 (en) Compositions, kits, and methods for providing and maintaining energy and metal alertness
JP3251287B2 (ja) カルシウム及び微量ミネラル補給品
CA2463668C (fr) Compositions et trousses comprenant un compose de bore defini, leurs procedes de preparation, leur utilisation et administration
US20020187219A1 (en) Low glycemic response compositions
US9884033B2 (en) Amino acid supplementation for a healthy microbiota ecosystem
JPS63287462A (ja) ペプチド栄養剤
CA2408611A1 (fr) Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages
CA2408610A1 (fr) Compositions a basse teneur en glucides, necessaires et methodes d'utilisation de ces compositions
JP4914594B2 (ja) 関節痛改善用食品組成物
WO2001093832A2 (fr) Compositions aqueuses de protection des cartilages présentant des contraintes posologiques déterminées pour une administration efficace
JPH0995448A (ja) 血中ビオチン濃度の増加方法およびビオチン含有飲食品
EP1289384A2 (fr) Compositions chondroprotectrices aqueuses dotees de limites de ph definies a des fins d'administration efficace
JP2010095474A (ja) カルシウム吸収促進組成物及びカルシウム吸収促進飲食物
JP2006342061A (ja) ミネラル含有水溶液組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead